Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(1.10)
# 3,613
Out of 4,408 analysts
17
Total ratings
38.5%
Success rate
-4%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATYR aTyr Pharma | Upgraded: Buy | $3.5 | $0.4404 | +694.73% | 1 | May 20, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $35.92 | - | 1 | May 20, 2026 | |
| ATRA Atara Biotherapeutics | Upgraded: Hold | $10 | $10.41 | -3.94% | 1 | May 18, 2026 | |
| AMGN Amgen | Upgraded: Buy | $375 | $355.20 | +5.57% | 1 | May 7, 2026 | |
| BIIB Biogen | Upgraded: Buy | $245 | $200.05 | +22.47% | 1 | May 1, 2026 | |
| INGN Inogen | Initiated Coverage: Buy | $12 | $6.40 | +87.50% | 1 | Apr 7, 2026 | |
| ANGO AngioDynamics | Initiated Coverage: Buy | $16 | $12.10 | +32.23% | 1 | Apr 6, 2026 | |
| GOCO GoHealth | Downgraded: Hold | $1.5 | $0.2901 | +417.06% | 1 | Apr 6, 2026 | |
| IRMD IRADIMED CORPORATION | Initiated Coverage: Buy | $116 | $93.55 | +24.00% | 1 | Apr 2, 2026 | |
| INTS Intensity Therapeutics | Upgraded: Buy | $20 | $3.62 | +452.49% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.75 | +242.86% | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $15.31 | +141.67% | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.65 | +136.56% | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $8.56 | +51.87% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $37.14 | -21.92% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $4.70 | n/a | 1 | Mar 18, 2025 |
aTyr Pharma
May 20, 2026
Upgraded: Buy
Price Target: $3.5
Current: $0.4404
Upside: +694.73%
Sionna Therapeutics
May 20, 2026
Downgraded: Hold
Price Target: n/a
Current: $35.92
Upside: -
Atara Biotherapeutics
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $10.41
Upside: -3.94%
Amgen
May 7, 2026
Upgraded: Buy
Price Target: $375
Current: $355.20
Upside: +5.57%
Biogen
May 1, 2026
Upgraded: Buy
Price Target: $245
Current: $200.05
Upside: +22.47%
Inogen
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.40
Upside: +87.50%
AngioDynamics
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $12.10
Upside: +32.23%
GoHealth
Apr 6, 2026
Downgraded: Hold
Price Target: $1.5
Current: $0.2901
Upside: +417.06%
IRADIMED CORPORATION
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $93.55
Upside: +24.00%
Intensity Therapeutics
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $3.62
Upside: +452.49%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $1.75
Upside: +242.86%
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $15.31
Upside: +141.67%
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $4.65
Upside: +136.56%
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $8.56
Upside: +51.87%
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $37.14
Upside: -21.92%
Mar 18, 2025
Maintained: Buy
Price Target: $13
Current: $4.70
Upside: n/a